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Abstract
The resistance of epithelial cells infected with Chlamydophila pneumoniae for apoptosis has been attributed to the induced
expression and increased stability of anti-apoptotic proteins called inhibitor of apoptosis proteins (IAPs). The significance of
cellular inhibitor of apoptosis protein-1 (cIAP-1) in C. pneumoniae pulmonary infection and innate immune response was
investigated in cIAP-1 knockout (KO) mice using a novel non-invasive intra-tracheal infection method. In contrast to
wildtype, cIAP-1 knockout mice failed to clear the infection from their lungs. Wildtype mice responded to infection with a
strong inflammatory response in the lung. In contrast, the recruitment of macrophages was reduced in cIAP-1 KO mice
compared to wildtype mice. The concentration of Interferon gamma (IFN-c) was increased whereas that of Tumor Necrosis
Factor (TNF-a) was reduced in the lungs of infected cIAP-1 KO mice compared to infected wildtype mice. Ex vivo
experiments on mouse peritoneal macrophages and splenocytes revealed that cIAP-1 is required for innate immune
responses of these cells. Our findings thus suggest a new immunoregulatory role of cIAP-1 in the course of bacterial
infection.
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Introduction
C. pneumoniae is a Gram-negative obligate intracellular bacterium
responsible for pulmonary infectious diseases. The presence of this
pathogen in atheromatous plaques implicates its association with
cardiovascular diseases such as atherosclerosis which leads to
coronary heart disease, one of the major factors responsible for
worldwide mortalities.
C. pneumoniae infection starts with the attachment of the virulent
and metabolically inert form of the bacteria known as elementary
bodies (EB) to epithelial cells. This is followed by a unique bi-
phasic life cycle in which EBs differentiate into the non-virulent
and metabolic active form called reticulate bodies (RBs) [1]. C.
pneumoniae infects cell types other than epithelial cells in the course
of infection, such as endothelial cells, smooth muscle cells, alveolar
and blood macrophages [2–5]. Among these, macrophages have
gained significant attention in recent years because they engulf
these bacteria and transmit them from lungs to peripheral
lymphoid tissues for elimination [6]. Macrophages are the key
players in the innate immune defense against various intracellular
bacterial infections [7]. They reside in almost all tissues
constituting the ‘mononuclear phagocyte system’. This complex
network enables the immune system to effectively sense the
microbial invaders and eliminate them from the body. Upon
recognition of pathogen-associated molecular patterns [8] or
molecules released by damaged host cells, referred to as ‘‘danger
signals’’ [9], macrophages manifest a strong inflammatory
response characterized by secretion of various mediators like
TNF-a, IFN-c, IL-8 and nitric oxide. Together these effector
molecules confer immune defense against various intracellular
bacterial infections including C. pneumoniae [10].
During the early phase of infection, Chlamydia induce anti-
apoptotic pathways conferring resistance of the infected host cells
to apoptotic stimuli like TNF-a, cycloheximide, staurosporine,
FasL, UV and gamma irradiation [11–13]. Recently, it has been
shown that resistance of infected cells for apoptosis induction is
due to the induced expression and increased stability of anti-
apoptotic IAPs, like X-chromosome linked (XIAP), and cellular
(cIAPs) inhibitors of apoptosis [14,15]. IAP proteins, originally
found in the baculovirus, are evolutionary conserved from insects
to humans and play a principle role in regulating apoptosis [16].
Although several members of the human IAP family of proteins,
including XIAP, cIAP-1 and cIAP-2, interact with caspase-3, 7
and 9 and block apoptosis if over expressed in cells [17,18], the
function of IAPs in vivo is still unknown. XIAP is probably the only
potent direct inhibitor of caspase-3, 7 or 9 [19], but an apoptosis
related phenotype has not yet been identified in XIAP knockout
mice [20]. A recent report suggests that IAPs are multifunctional
signaling devices that influence innate immunity in Drosophila [21].
Human cIAP-1 and cIAP-2 may play a role in controlling the
tumor necrosis factor pathway since they have been shown to
interact with TNF receptor complex components, TRAF1 and
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NF-kB activation has been demonstrated in knockout mice [24].
cIAP-2 knockout mice also displayed an attenuated inflammatory
response and profound resistance to LPS in experimental
endotoxic shock. Furthermore, cIAP-2 knockout macrophages
were reported to be highly susceptible to apoptosis in an LPS-
induced proinflammatory environment, indicating that cIAP-2 is a
critical factor in maintaining normal innate immune responses
[24]. Recently, it has been suggested that XIAP is involved in
innate immune responses to control Listeria infection in mice [25].
Here we present data demonstrating a compromised immuno-
competence of cIAP-1 KO mice against C. pneumoniae infection.
Macrophages from cIAP-1 KO mice were severely affected in
bactericidal innate immune signaling pathways. We propose a new
function for inhibitor of apoptosis proteins in the control of
infection with obligate intracellular C. pneumoniae.
Results
Increased sensitivity of cIAP-1 KO mice for C. pneumoniae
infection
To investigate if cIAP-1 is involved in the control of chlamydial
infection, both wildtype and cIAP-1 KO mice were infected using
a non-invasive intratracheal infection method (for details see
Materials and Methods). The infection of different mouse organs
was monitored by demonstrating the presence of bacterial DNA
by nested PCR (Table S1 and S2). Amongst all organs tested,
lungs were consistently infected with C. pneumoniae at day 3, 10 and
20 post infection (d. p.i) in wildtype and cIAP-1 KO mice (Table
S2). Chlamydial inclusions could be detected in infected mouse
lungs as early as 3 d.p.i. (Fig. S1). However, quantitative real-time
PCR revealed a gradual reduction of bacterial load in lungs of
infected wildtype mice, whereas in cIAP-1 KO mice levels
remained high (Fig. 1A). In contrast to wildtype mice, cIAP-1
KO mice failed to control the lung infection with C. pneumoniae.
To compare the load of viable bacteria in the lung of infected mice,
lung infectivity assays were performed. Lungs of non-infected and
infected animals were homogenized and infectious chlamydial
particles were determined by infecting fresh HEp2 cells and by
counting inclusions by automated microscopy. These assays revealed
an increase in infectious bacteria in lungs of wildtype infected mice
from day 3 to day 10 post-infection which decreased until day 20 post
infection (Fig. 1B,C). In contrast to wildtype mice, cIAP-1 KO mice
were unable to resolve the infection. During the whole experimental
period the amount of infectious bacteria gradually increased
(Fig. 1B,C). Taken together, these results demonstrated an increased
sensitivity of cIAP-1 KO mice to C. pneumoniae lung infection.
Figure 1. Sensitization of cIAP-1 KO mice for C. pneumoniae
lung infection. A. Five mice per group were infected with C.
pneumoniae and the chlamydial ompA gene was amplified from the
lung tissue of each mouse (as described in Supporting Materials and
Methods S1). The relative amount of the ompA gene in each lung
sample was calculated using GAPDH as an internal control. ** p#0.01.
B. Impaired resolution of C. pneumoniae infection from the lungs of
cIAP-1 KO mice. Five mice per group were infected with C. pneumoniae
and infectious bacteria were determined by lung infectivity assays as
described in Materials and Methods. HEp2 epithelial cells were infected
with lung homogenate at different time points post infection and
infectivity was analyzed by quantitative immuofluoresence microscopy.
Infectivity was calculated as the number of chlamydial inclusions
formed per infected HEp2 cell (cIAP-1 KO infected 0.7360.023; WT
infected 0.2860.06 at day 20). The data represent the mean6SEM of
inclusion numbers per cell from three independent experiments. C.
Microscopic images of the chlamydial inclusion formed in HEp2 cell
after infection with lung homogenate. The blue color represents the
nuclei (Hoechst stain) of the HEp2 cell infected and the red color shows
the Chlamydia inclusion (Cpn; arrowheads) formed per cell. The red
background staining in the control samples is probably due to
unspecific antibody aggregate formation.
doi:10.1371/journal.pone.0006519.g001
cIAP-1 Controls Lung Infection
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To obtain first indications of the mechanism underlying the
different outcomes of lung infection in wildtype and cIAP-1 KO
mice, lungs of infected and non-infected animals were analyzed for
production of inflammatory cytokines. Histopathological analyses
indicated an increased accumulation and recruitment of inflam-
matory (CD68+) alveolar macrophages in lungs of wildtype mice
in response to C. pneumoniae infection (Fig. 2A). These macrophages
were located close to bacterial inclusions in infected lungs of
wildtype mice. Accumulation of the inflammatory macrophages in
lungs of wildtype mice in response to infection indicated a
chemotactic response, which was found to be compromised in the
infected lung of cIAP-1 KO mice.
We next quantified the inflammatory response by determining
IFN-c andTNF-atitersinlungsofwildtype and cIAP-1KOmicein
response to infection. C. pneumoniae infection caused an increase in
pulmonary IFN-c and TNF-a in both wildtype and cIAP-1 KO
mice as compared to the non-infected control (Fig. 2B,C,D).
Infected cIAP-1 KO mice produced higher pulmonary IFN-c titers
than infected wildtype mice. These data demonstrated a partial de-
regulation of the inflammatory response of cIAP-1 KO mice.
cIAP-1 is required for the production of TNF-a in
macrophages
To understand the reason for the dysregulated inflammatory
response in cIAP-1 KO mice, innate immune functions of wildtype
and cIAP-1 KO macrophages were analyzed. Because increased
expression of closely related cIAP-2 might counterbalance the loss
of functional cIAP-1 [33], the expression level of cIAP-2 was
checked by immuoblot analysis. No increase of cIAP-2 level was
observed in macrophages whereas in lung tissue elevated levels of
cIAP-2 were observed (Fig. S2, 3A,B). Peritoneal macrophages
from both wildtype and cIAP-1 KO mice were stimulated with
bacterial LPS (Fig. 3C) and/or infected with C. pneumoniae (Fig. 3D).
Treatment of wildtype macrophages with increasing doses of LPS
(1–5 mg/ml) resulted in a dose-dependent stimulation of TNF-a
secretion. cIAP-1 KO macrophages responded similarly to LPS
treatment, however, TNF-a titers remained significantly lower
than in wildtype macrophages (Fig. 3C). This tendency was also
observed if macrophages were infected or stimulated with LPS and
infected with C. pneumoniae (Fig. 3D). These findings together
indicated a possible role of cIAP-1 in the LPS- and infection-
induced production of TNF-a in macrophages.
The defects observed in LPS- and infection-induced TNF-a
production in cIAP-1 KO macrophages could be restricted to LPS-
induced pathways. We therefore stimulated macrophages with IFN-
c, which stimulates TNF-a production via NF-kB independent of
LPS [26]. However, cIAP-1 KO macrophages produced signifi-
cantly less TNF-a compared to wildtype macrophages (Fig. 3E),
ruling out a LPS-specific defect in these macrophages.
cIAP-1 is required for the production of NO in
macrophages
Another important mediator involved in the bactericidal effect
of macrophages is nitric oxide (NO) free radical. Treatment of
wildtype macrophages by bacterial endotoxin induced the
generation of significant amounts of NO in a dose- and time-
dependent fashion (Fig. 4A). In contrast, cIAP-1 KO macrophages
had a strongly diminished capacity to produce NO upon LPS
stimulation. C. pneumoniae infection of wildtype macrophages
induced only low amounts of NO 24 h post infection (not shown),
which was modestly but significantly higher at 48 h post infection
in comparison to the uninfected control (Fig. 4B). In contrast,
cIAP-1 KO macrophages did not show any increase in NO upon
infection during the experimental period (Fig. 4B).
To test whether cIAP-1 is involved in innate stimulation of NO
production,westimulated thesemacrophageswithdifferentdosesof
Figure 2. Dysregulated inflammatory responses of cIAP-1 KO
mice. A. Reduced numbers of macrophages in lungs of infected cIAP-1
KO mice. The lungs from mice either non-infected or infected for 20
days were excised aseptically and 5 mm pieces were fixed and
sectioned. The sections were stained with rabbit anti-Chlamydia LPS
antibody and Cy3-conjugated secondary antibody, and with anti-CD68
antibody detected with Alexa-488 conjugated secondary antibody to
localize C. pneumoniae and alveolar macrophages, respectively. The
lung epithelial cells were stained with Hoechst and examined
microscopically by using a fluorescent microscope under 406of
objective. The figure shows a typical example of at least five
independent infections. B, C. Levels of IFN-c (B) and TNF-a (C) were
determined in lung homogenates from wildtype and cIAP-1 KO mice by
ELISA at different time points post infection. Data represent the
mean6SEM from five independent infection experiments. * p#0.05; **
p#0.01.
doi:10.1371/journal.pone.0006519.g002
cIAP-1 Controls Lung Infection
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of wildtype macrophages induced production of NO in a dose-
dependent manner (Fig. 4C). cIAP-1 KO macrophages failed to
produce significant levels of NO in response to TNF-a. The lack of
NO production by KO macrophages upon TNF-a stimulation was
not due to reduced viability of the treated cells (Fig. S3). In contrast
to TNF-a, treatment of macrophages with IFN-c elicited similar
NO responses in wildtype and KO macrophages, demonstrating
that cIAP-1 KO macrophages have a stimulus-dependent defect in
NO signaling (Fig. 4D).
NO is mainly produced by the inducible NO synthase (iNOS) in
macrophages [27]. The clear defect of cIAP-1 KO macrophages in
NO production prompted us to investigate whether these cells are
affected iniNOS expression.Interestingly,LPSorTNF-a treatment
induced iNOS expression in wildtype, but not in cIAP KO
macrophages (Fig. 4E). In contrast, IFN-c caused the up-regulation
of iNOS in both wildtype and KO (Fig. 4E) ruling out a general
defect in iNOS expression in the KO mice. Because cIAP-1 has
been implicated in the control of apoptosis, we investigated the
effect of these treatments on the induction of apoptosis in wildtype
and mutant macrophages. Since none of the treatments elicited a
significant increase in the apoptotic population or affected the
viabilityof treatedmacrophages (Fig.S3),the reduced production of
NO by mutant macrophages in response to certain stimuli was not
due to increased cell death in these cases. These data suggested that
the defect of cIAP KO macrophages in inducing NO originated
from a defect in the stimulus dependent up-regulation of iNOS.
Resistance of cIAP-1 KO mice to endotoxin shock
TNF-a and NO are the key mediators of endotoxin-mediated
toxicities. Since cIAP-1 KO macrophages were clearly affected in
their production of TNF-a and NO, we expected an increased
resistance of these mice to endotoxin-induced toxicities. We
therefore determined the dose of lethal endotoxin-induced shock
in wildtype and cIAP-1 KO mice. Wildtype mice died in a dose-
dependent fashion; for example, a dose of 0.5 mg/kg body weight
of bacterial LPS evoked 100% mortality within 96 h post
induction of shock in wildtype mice (Fig. 4F). In contrast, 60%
of the cIAP-1 KO mice survived treatment with the same dose of
LPS (Fig. 4G), demonstrating a significantly increased resistance of
these mice for LPS-induced shock. In contrast to the LPS-induced
shock, we found no difference in survival and bacterial load in the
spleen after i.v. challenge of wildtype and cIAP-1 KO mice with
Figure 3. cIAP-1 is required for endotoxin- (LPS) and IFN-c-
induced inflammatory response. A. cIAP-2 is upregulated in the
lungs of knockout mice. Lung homogenates from wildtype ad knockout
mice were subjected to immunoblot analysis for the quantification of
cIAP-2 and XIAP as described in Materials and Methods. b-tubulin was
detected as a loading control. B. Densitometric quantification of the
data shown in figure 3A normalized for b-tubulin as loading control. C.
The isolated peritoneal macrophages from both wildtype and cIAP-1 KO
mice were treated with different doses of LPS, and TNF-a was
determined in the culture supernatants 48 h post treatment. Data
represent the mean6SEM from three independent experiments. D.
Impaired TNF-a production in infected cIAP-1 KO macrophages.
Macrophages were cultured and infected with C. pneumoniae at MOI
1 and/or treated with LPS at 5 mg/ml. TNF-a titers were determined in
the culture supernatants 48 h post infection and treatment. Data are
presented as the mean6SE from three independent experiments. E.
cIAP-1 is required for IFN-c-mediated production of TNF-a. Peritoneal
macrophages from wildtype and cIAP-1 KO mice were isolated and
stimulated with different doses of mouse IFN-c ex vivo. The supernatant
were collected at 48 h after stimulation and TNF-a titers were
quantified by ELISA. Data represent the mean6SEM from two
independent experiments. * p#0.05; ** p#0.01.
doi:10.1371/journal.pone.0006519.g003
cIAP-1 Controls Lung Infection
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additional mechanisms besides endotoxin exposure cause toxicity
in the case of Salmonella infection.
C. pneumoniae infection elicits cytotoxicity on
macrophages
The depletion of macrophages from the lungs of infected cIAP-1
KO mice raised the question whether infection directly affects
survival of macrophages. We therefore investigated the role of cIAP-1
in the survival and proliferation of macrophages in response to C.
pneumoniaeinfectionand/ormitogenicstimuli.TotestwhethercIAP-1
affects the infection efficiency, macrophages from wildtype and cIAP-
1 KO animals were infected and the inclusions were detected by
immunofluorescence microscopy. Inclusions could be detected at
similar quantities in wildtype and KO macrophages ruling out a
major role of cIAP-1 in infection of C. pneumoniae(Fig. 5A,B). We next
tested whether infection or LPStreatment affected the proliferation of
Mac-1-positive macrophages differently. Macrophages were treated
with LPS and the metabolic activity was measured using the WST
assay. If treated with LPS, cIAP-1 KO macrophages exhibited less
metabolic activity compared to wildtype macrophages (Fig. 5C,D). A
decrease in metabolic activity was observed upon infection of both,
wildtype and KO macrophages with C. pneumoniae (Fig. 5E). A similar
result was obtained when the survival of treated and infected
macrophages was measured using the MTT assay (Fig. 5F). We also
observed the loss of infected cIAP-1 KO macrophages from the cell
culture plate after prolonged infection (Fig. 6A,B). To further
characterize the reason for the cell loss, LDH release and caspase 3/7
activation was measured to assay necrotic and apoptotic cell death,
respectively. Whereas caspase 3/7 was not increased in KO
macrophages compared to wildtype cells, a small but significant
(p#0.05) increase in LDH activity could be measured in the culture
supernatants (Fig. 6C,D), suggesting a necrotic type of cell death
induced by C. pneumoniae infection.
Figure 4. cIAP-1 is required for nitric oxide production in response to LPS and TNF-a in peritoneal macrophages. A. Macrophages
from wildtype and cIAP-1 KO mice were stimulated with different doses of LPS and the NO titer was determined in the culture supernatant at the
indicated time points post treatment. B. LPS- and infection- (Cpn) induced NO production in cIAP-1 KO and wildtype macrophages. 1610
4 peritoneal
macrophages were infected with C. pneumoniae at an MOI of 1. Cells were treated with LPS 30 min after infection and further incubated at 37uC for
48 h. NO generation was quantified in culture supernatants. C. TNF-a-induced production of NO in cIAP-1 KO and wildtype peritoneal macrophages
24 h post treatment. Both wildtype and cIAP-1 KO macrophages were cultured and stimulated with the indicated doses of TNF-a and NO was
measured in the supernatant 24 h post induction. D. IFN-c-mediated NO production in KO and wildtype macrophages. 1610
6 macrophages were
stimulated with murine IFN-c and NO were determined in culture supernatants 48 h later. The data are presented as the mean6SEM from three
independent experiments. E. cIAP-1 is required for the induction of iNOS by LPS and TNF-a in mouse macrophages. The cells were incubated with the
indicated reagents and the levels of iNOS were determined by western blot of whole cell lysates. a-actin was detected as loading control. F and G.
Resistance of cIAP-1 KO mice against LPS-induced endotoxin shock. Mice were treated with different doses of LPS intraperitoneally (from 0.1 to
0.5 mg/kg body weight [b.w.]) and the survival of wildtype (F) and cIAP-1 KO mice (G) was monitored over a 14 day period. Shown are the
representative results of one out of three independent experiments. * p#0.05; ** p#0.01.
doi:10.1371/journal.pone.0006519.g004
cIAP-1 Controls Lung Infection
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To find out whether the defect observed was specific for
macrophages we tested other immune cells for their response to
mitogenic stimuli by
3H-thymidine uptake assays. Treatment of
splenic polymorphonuclear cells (PMC) and T cells (for details see
Supporting Materials and Methods S1) with LPS and Concanav-
Figure 5. Impaired growth of cIAP-1 KO macrophages. A. Peritoneal macrophages from wildtype and ciap-1 KO mice were harvested and
cultured in antibiotic free RPMI-1640 medium over night. Next day the macrophages were infected with C. pneumoniae at different MOI. 72 h post
infection, the macrophages were fixed with chilled absolute methanol and stained with anti C. pneumoniae antibody. Shown here is the
representative micrographs of the macrophage infected. B. Quantification of inclusions in macrophages. 1610
4 wildtype and cIAP-1 KO macrophages
were cultured in 96 well plates in antibiotic free medium and infected with different doses of C. pneumoniae. The cells were fixed and stained with
anti-C. pneumoniae antiserum. The inclusion in the macrophages were determined by automated microscopy as described in Materials and Methods.
Data are represented as mean6SEM from three independent experiments. C. Quantification of Mac-1+(CD11b+) peritoneal macrophages. The
macrophage from wildtype and cIAP-1 macrophage were treated with increasing doses of LPS and Mac-1+peritoneal macrophage were compared
among wildtype and KO mice. Shown here is the immune fluorescence picture of Mac-1+macrophages (green) and DNA (blue) and analyzed by
immunofluorescence microscopy. D. Mouse peritoneal macrophages from wildtype and cIAP-1 KO mice were stimulated ex vivo with different doses
of LPS and their survival was measured 48 h later by WST assay. E. Toxicity of C. pneumoniae infection on macrophages. Metabolic activity of infected
was determined by standard WST assays as described in Supporting Materials and Methods S1. Data are represented as mean of OD6SEM from three
independent experiments. F. The survival of macrophages under infection experiments was measured by standard MTT assays as described in
Supporting Materials and Methods S1. Data are represented as the mean OD6SEM from three independent repeats.
doi:10.1371/journal.pone.0006519.g005
cIAP-1 Controls Lung Infection
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wildtype and cIAP-1 KO cells. However, cIAP-1 KO leukocyte
were strongly compromised in their proliferation compared to
wildtype cells (Fig. 7A,B).
In conclusion, these data demonstrate the involvement of cIAP-
1 in the control of C. pneumoniae infection and the integrity of the
innate immune functions of mouse macrophages and splenocytes.
Discussion
C. pneumoniae infection induces the expression and increased
stability of inhibitor of apoptosis proteins IAPs, which confer resistance
of infected cells to apoptosis induced by different stimuli [14].
Based on this observation and since induction of apoptosis has
been suggested a potential strategy to activate anti-bacterial
responses required for the resolution of bacterial infections [28],
we assumed that inhibiting apoptosis of infected cells would ensure
bacterial survival. Interfering with infection-induced anti-apoptotic
signaling should confer resistance against bacterial infection. In
contrary to our expectations, cIAP-1 KO mice were clearly
Figure 6. Cytotoxicity of C. pneumoniae infection on macro-
phages. A and B. Phase contrast pictures of non-infected (control)
and infected macrophages from wildtype (WT) and cIAP-1 KO (KO) mice
were taken 24 h, 48 h and 96 h post infection at 406magnification.
Shown are representative pictures from one out of three independent
experiments. C. The culture supernatants from macrophages infected
as in figure 5 or 6A,B were taken and cytotoxicity of infection was
compared quantitatively by LDH release at 72 h post infection using the
LDH cytotoxicity detection kit (Roche). D. Both wildtype and cIAP-1 KO
macrophages were infected and stimulated with TNF-a and IFN and
activity of caspase-3 and -7 was quantified using Caspase-Glo
H
luminescent assay at 24 h post infection. * p#0.05.
doi:10.1371/journal.pone.0006519.g006
Figure 7. Impaired stimulatory potential in splenocytes from
cIAP-1 KO mice. A and B. 1610
6 PMC (A) and splenic T cells (B) from
wildtype and cIAP-1 KO mice were stimulated with different doses of
LPS and Con A, respectively, and the stimulatory potential was
measured by
3H-thymidine incorporation. Data represent the mean of
counts per minutes CPM6SEM from three independent experiments. *
p#0.05; ** p#0.01.
doi:10.1371/journal.pone.0006519.g007
cIAP-1 Controls Lung Infection
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supporting a role of cIAP-1 in the immune response against these
obligate intracellular bacteria.
Accumulating evidence suggests that cIAP-1 and cIAP-2 are
involved in signal transduction including the NF-kB pathway [29–
32]. Recent data demonstrated a key role of these IAPs in the
control of TNF-a-induced NF-kB signaling. However, cIAP-1 and
cIAP-2 exert redundant functions in this signaling pathway [29].
Moreover, the cIAP-1 knockouts were initially reported to have no
overt phenotype, because of compensation by the up-regulation of
cIAP-2 in various tissues and cells such as spleen, thymus and
MEFs [33]. We observed the up-regulation of cIAP-2 in lung
tissue, but not in macrophages of cIAP-1 knockout mice. Due to
the clear phenotype of the cIAP-1 knockout mice, we postulate a
non-redundant role of cIAP-1 in chlamydial lung infection. This
does not exclude a function of cIAP-2 in chlamydial lung infection
since both may be organized in functional complexes [15].
C. pneumoniae infection induces secretion of inflammatory
mediators like IFN-c in host macrophages, which is crucial for
their anti-bacterial defense via induction of TNF-a [34]. It was
therefore expect that increased titers of IFN-c in the lungs of
infected cIAP-1 KO mice results in the increased production of
TNF-a. However, infected cIAP-1 KO mice had lower TNF-a
titers than wildtype mice. This could be due to either the depletion
of alveolar macrophages or their reduced recruitment to the lungs
of infected cIAP-1 KO mice. These assumptions are supported by
our comparative histo-pathological analyses of lungs from infected
KO and wildtype animals (Fig. 2A). We found an increased
sensitivity of cIAP-1 KO macrophages for high concentrations of
TNF-a in vitro (not shown) compared to macrophages from
wildtype animals. It is thus possible that macrophages from cIAP-1
KO mice undergo apoptotic cell death in the inflamed lung tissue,
as suggested for cIAP-2 knockout mice [24]. However, enhanced
macrophage apoptosis alone probably does not account for the
increased infection of the cIAP-1 KO mice we observed, because
macrophage apoptosis in the fully immune competent animal
rather supports the clearance of lung infections [28]. Furthermore,
we could not observe the sensitization for apoptosis of macro-
phages from KO versus wildtype animals upon infection with C.
pneumoniae or treatment with different stimuli (Fig. 6B and S3). We
therefore assumed a defect in the innate immune response was
responsible for the reduced macrophage numbers and increased
bacterial load of infected animals.
Among various virulent factors, C. pneumoniae LPS and HSP60
are well known stimulators of macrophage-mediated inflamma-
tory responses which manifest a strong anti-bacterial defense
[35,36]. In line with a dysfunction of the cIAP-1 KO
macrophages in these signaling pathways, LPS treatment or C.
pneumoniae infection induced the production of TNF-a in the
supernatant of wildtype macrophages whereas the response of
knockout macrophages was reduced. A similar defect has been
observed in cIAP-2 KO mice, which showed a profound
resistance against LPS-induced inflammatory responses [24].
However, cIAP-1 KO mice were not only affected in LPS-
triggered signaling pathways leading to TNF-a secretion. The
response to IFN-c treatment was also strongly reduced compared
to wildtype macrophages, demonstrating an impaired IFN-c
induced signaling to TNF-a production in the cIAP-1 KO
macrophages. Since TNF-a is one of the central cytokines
involved in anti-chlamydial defense in both epithelial cells and
macrophages [37,38], the reduced production of TNF-a in the
lungs and macrophages of cIAP-1 KO mice is very likely one of
the main reasons for the opportunistic survival of C. pneumoniae in
the lungs of infected cIAP-1 KO mice.
Production of inducible NO is another potent mechanism by
which macrophages kill bacterial pathogens in general [27,39] and C.
pneumoniae in particular [40,41]. NO is generated by nitric oxide
synthases (NOS). Of the three NOS isotypes found in mammalian
cells, NOS2 also called iNOS (inducible or independent of elevated
Ca
2+) is most important in the context of infection, inflammation and
immune regulation [27,39]. We found a strong decrease in NO
production in macrophages from cIAP-1 KO mice stimulated with
LPS and TNF-a compared to wildtype cells. Interestingly, this effect
was not observed if macrophages were treated with IFN-c suggesting
that cIAP-1 is involved in specific signaling pathways leading to the
generation of NO. The block in NO production in cIAP-1 KO
macrophages is probably upstream of iNOS induction since inducers
which triggered a cIAP-1-dependent increase in NO (LPS, TNF-a)
also induced iNOS expression. However, stimulation of NO in
wildtype and cIAP-1 KO macrophages by IFN-c remained
comparable and redundant (Fig. 4), indicative of cIAP-1-independent
stimulation of NO by IFN-c. This is especially interesting since
induction of murine iNOS by LPS also involves the IFN-c pathway,
as demonstrated previously in IFN-c [42], IFN-c receptor [43] and
STAT-1 [44] deficient mice. Since cIAP-1 KO macrophages express
normal amounts of the LPS receptors, CD14 and TLR4 (HP and
TR, unpublished), we speculate that cIAP-1 acts downstream of LPS
receptors and upstream of IFN-c induction to up-regulate iNOS.
We found an increased resistance of cIAP-1 mice for endotoxic
shock induced by LPS treatment. Mortality of KO and wildtype
mice infected with Salmonella was, however, similar, suggesting
unknown mechanisms besides endotoxin exposure causing toxicity
in case of infection. Salmonella infection of macrophages is known to
activate different pathways leading to cell death [45]. One of these,
called pyroptosis because of its proinflammatory effect, is a caspase-
1-dependent form of cell death dependent on the Salmonella type-
three secretion system (T3SS) and effectors [46]. As caspase-1 KO
mice are resistant to Salmonella infection [47], pyroptosis induced by
Salmonella may not be influenced by cIAP-1 in vivo.
There are at least two different possible mechanisms by which
cIAP-1 KO mice resist endotoxin shock. Firstly, increased
sensitivity of LPS treated cIAP-1 KO macrophages to cell death
(see Fig. 5) may lead to the depletion of macrophages upon
induction of a systemic inflammatory response. As a consequence,
a major source for proinflammatory cytokines is ablated leading to
an attenuated immune response and protection from shock. This
scenario has been suggested as mechanism for endotoxin shock
resistance of cIAP-2 KO mice [24]. However, the finding of severe
defects in TNF-a production by cIAP-1 KO mice and the
induction of iNOS upon TNF-a and LPS challenge shifts the focus
to NO as an effector of shock. Systemic TNF treatment provokes a
lethal shock syndrome, in which cardiovascular collapse is
centrally orchestrated by NO [48]. Several lines of evidence
support an important role for the vasodilator NO in hypotension,
a hallmark of septic shock [49,50]. The reduced response of cIAP-
1 KO macrophages and splenocytes to proliferate in response to
LPS and Con A treatment may well contribute to the resistance of
these animals for LPS-induced endotoxin shock.
These findings suggest that, besides their role in apoptosis
regulation, IAPs play a prominent role in innate and adaptive
cellular immunity.
Materials and Methods
Ethics statement
Animal testing was performed according to German Animal
Protection law (TierSchG). The application for the experiments
was reviewed by the responsible local authorities, Landesamt fu ¨r
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No. G0325/05).
C. pneumoniae stock
C. pneumoniae strain VR1310 was propagated in HEp-2 cells.
These cells were infected with C. pneumoniae and lysed by
mechanical disruption with a rubber policeman 72 hour post
infection. Bacteria were subsequently harvested by centrifugation
at 5006g at 4uC for 10 min. The pellet was ruptured using glass
beads and the lysates were centrifuged as before. The supernatants
were removed and centrifuged at 45,0006g for 45 min at 4uCi na
SS34 rotor (Sorvall Instruments) to pellet Chlamydia. The bacteria
were resuspended in SPG (sucrose-phosphate glutamate) buffer
and stored at 280uC.
Non-invasive intratracheal infection of mice
A novel non-invasive spray method was established for infecting
mice with C. pneumoniae. Mice were anesthetized by intraperitoneal
injection of Ketamine (120 mg/kg) and Xylazine (16 mg/kg) and
placed backwards on a small box. A microsprayer (Penn-Century,
Philadelphia, PA) was placed oropharyngeally into the trachea
with the help of a laryngoscope and a binocular light microscope,
and mice were infected by aerosolizing 5610
6 bacteria in 25 ml
SPG buffer into the airways. Control mice were kept on placebo
and received the same amount of SPG buffer. Mice were routinely
examined and the infectivity was monitored over the schedule of
21 days. The body weight of each mouse and other toxicological
measurements were recorded over the course of infection.
Lung infectivity assay
Bacterial load in the lung of infected mice was monitored by
conventional lung infection assay [51]. The lungs of mice were
kept separately in the infecting medium (RPMI+5% FCS), minced
mechanically using a mesh and homogenized using a tissue
homogenizer to obtain a suspension. The cellular debris and
fibrous tissues were removed by passing the homogenate through a
40 mm cell strainer. The filtrate was centrifuged at 5006g for
10 min at 4uC and the resulting supernatant contained chlamydial
elementary bodies. Fresh HEp2 cell monolayer was used to infect
in 96 well plates by centrifugation at 7006g at RT for 1 h. After
centrifugation plates were incubated in 5% CO2 at 35uC for 1 h
before the medium was replaced with fresh RPMI containing 5%
FCS, 1% Gentamycin and 1 mg Cycloheximide and the culture
was kept in a CO2 incubator at 35uC further for 72 h.
Immunostaining and automated microscopy
For staining the chlamydial inclusion, the cell monolayer was
blocked with PBS+0.2% BSA for 1 h and incubated with mouse
anti C. pneumoniae antibody (Ab-Cam) for 1 h at RT. After
washing, cells were further incubated with Cy3-conjugated affinity
purified goat anti mouse IgG (monoclonal) antibody for 1 h at RT.
The cell nuclei were stained with Hoechst dye. Images were
acquired by a Scan R automated microscope system (Olympus)
using UPLSAPO lenses (106magnification) as previously de-
scribed [52]. Infectivity was calculated as the number of
chlamydial inclusions per cell using the Scan R-Analysis software.
Histopathology of lung tissue
For histopathological analysis, mouse lungs were cut in 5 mm
long pieces and fixed with 4% PFA for 1 h at RT. The tissues were
washed, air dried and blocked by placing tissues in cryo-stat
medium at 220uC. Ten mm sections were cut in a cryotome (Leica)
and air dried in a closed box at 4uC over night. The next day, these
sections were blocked with 2% FCS/TBS for 1 h at RT. The
sections were probed with rabbit anti- Chlamydia LPS and anti
mouse CD68 markers to stain C. pneumoniae and macrophages,
respectively. After 3 washes with TBS at RT, the sections were
incubatedwithantirabbitCy3-conjugatedIgGforC.pneumoniaeand
anti rat Alexa 488 for macrophages for 1 h at RT. Lung epithelial
cells were visualized by staining them with Hoechst dye for 5 min at
RT. The sections were washed three times with TBS, rinsed shortly
with distilled water and mounted on coverslips. The sections were
analyzed using fluorescence microscopy under 406magnification.
Total nitrite production
Supernatants from macrophages were used to determine NO as
nitrite (a stable form of NO) by the standard Griess reagent assay.
Equal volumes of the culture supernatants and Griess reagent (1%
sulphanilamide/0.1% N-(naphthyl) ethylene-diaminedihydrochlor-
ide in 1:1 ratio) were mixed and absorbance was measured at
550 nm by Spectra max spectrometer (Molecular Devices). The
amount of nitrite produced in samples was calculated against a
NaNO2 standard curve by using the SPF program.
ELISA for cytokines
TNF-a and IFN-c titers in the lung homogenates and/or
macrophages culture supernatants were measured by using an
ELISA kit (BD Pharmingen, USA). Polystyrene plates (Maxisorp,
Nunc, USA) were coated with monoclonal anti-cytokine antibody
and incubated overnight at 4uC. The plates werewashed and blocked
with PBS+10% FBS for 1 h. Recombinant cytokine standards and
samples were incubated for 2 h at RT. After washing, plates were
further incubated with biotinylated detection antibody for 1 h at
25uC. Substrate solution was added and plates were incubated for
10–30 min at RT. The reaction was stopped and the plates were read
at 492 nm by a multiwell spectrometer, Spectra max 250 (Molecular
Devices). Cytokine concentrations in samples were calculated by SPF
software using a recombinant cytokine standard curve.
Westernblotting for IAPs
Lungs of KO and WT animals were washed with PBS and
homogenized in 3 volumes RIPA buffer (10 mM Tris/HCl
[pH 7,5], 130 mM NaCl, 1% Triton X-100, 0,02% SDS,
phosphatase inhibitor [PhoSTOP], protease inhibitor [complete]).
After incubation on ice for 1 h, the lysates were sonificated for
10 sec and cleared by centrifugation for 30 min at 4uC and
14,000 rpm. The middle layer containing proteins was centrifuged
as above for additional clearing and protein amounts were
determined by Bradford assay. For detection of XIAP, lysates
were incubated with Sepharose G beads over night at 4uCt o
reduce serum IgGs. 26Laemmli buffer (100 mM Tris/HCl
[pH 6,8], 20% glycerin, 4% SDS, 1,5% 2-mercaptoethanol,
0,2% bromphenol blue) was added to the lysates and boiled at
95uC for 5 min. Protein lysates were separated by SDS-PAGE and
transferred to a PVDF membrane (GE Healthcare). After blocking
for 1 h with 5% skimmed dry milk in TBS containing 0.5%
Tween-20 (TBST), the membrane was decorated over night at
4uC with the following primary antibodies: rabbit polyclonal cIAP-
2 (H-85) and beta-Tubulin (H-235) (Santa Cruz) and mouse
monoclonal XIAP (BD Transduction). Antibody-antigen com-
plexes were detected by HRP-linked donkey anti-rabbit or sheep
anti-mouse secondary antibodies (GE Healthcare).
Western blotting for iNOS
Peritoneal macrophage treated with various inflammatory
inducers (LPS, IFN-c and TNF-a) were lysed in 50 mM Tris-
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and protease inhibitor mixture and sonicated. The lysate was
centrifuged at 14,000 rpm for 20 min at 4uC to separate cytosol
and particulate fraction. Protein concentration was determined by
the Bradford method (Bio-Rad, Munich, Germany). Proteins
(10 mg for each lane) were separated on 7.5% SDS-PAGE and
blotted on PVDF membrane by wet electroblotting. Blots were
blocked overnight at 4uC with 5% non-fat dry milk in TBS-T at
pH 7.5 (20 mM Tris base, 137 mM NaCl, and 0.1% Tween 20)
and then incubated for 2.5 h with anti-iNOS (BD Pharmingen,
Heidelberg, Germany) followed by the HRP conjugated secondary
antibody. Blots were developed by ECL (Amersham, Life Sciences,
Freiburg, Germany) and actin was used as a loading control for
normalization.
Splenocyte primary cell culture and proliferation
The spleens from both wildtype and cIAP-1 KO mice were
excised aseptically and a single cell suspension was prepared as
previously described [53]. The spleens was kept in serum free
RPMI 1640 medium and crushed between two frosted-end slides.
The splenic homogenate was filtered through 40 mM cell strainer
for the removal of tissue and debris. The suspension was carefully
transferred to a 15 ml conical centrifuge tube and centrifuged at
1,500 rpm for 10 min, 4uC. RBCs were removed by RBC lysing
buffer (0.1 M NH4Cl). Lymphocytes were separated from
adherent PMN and monocytes by adherence method. For that
purpose the single cell suspension so prepared was incubated at
37uC for 3 h and floating lymphocytes were collected, centrifuged
at 1,500 rpm, 10 min at 4uC and resuspended in RPMI 1640
medium supplemented with 10% heat-inactivated FBS, 15 mM
HEPES buffer, 2 mM L-glutamine and 1% Gentamycin. The
viable lymphocytes were counted by trypan blue dye exclusion
method. These lymphocytes were stimulated with Con A for
inducing their proliferation. The PNM cells were separated from
lymphocytes in similar way and stimulated with LPS for inducing
their proliferation in flat bottom 96-well polystyrene microtiter and
their proliferation was measured by tritiated thymidine (
3H-Td)
uptake method. Cells after 72 h post treatment were pulsed with
0.5 mCi
3H-Td (18.5kBq) for 18 h and harvested on the glass fiber
filter mats by using cell harvester. Radioactivity was counted by
using liquid scintillation counter (Perkin Elmer).
Experimental endotoxin shock
For inducing endotoxin shock, both wildtype and cIAP-1 KO
mice (8–10 wk old, 5 per group) were administered various (sub-
and supra-lethal) doses of bacterial endotoxin (LPS; Salmonella
Typhimurium Sigma) in 0.2 ml volume of non-pyrogenic saline,
intraperitoneally. Control mice were administrated the same
volume of normal non-pyrogenic-saline. Survival of wildtype and
cIAP-1 KO mice was compared during the observation period of
one week.
Supporting Information
Materials and Methods S1
Found at: doi:10.1371/journal.pone.0006519.s001 (0.06 MB
DOC)
Figure S1 Infection of mouse lungs with Chlamydophila
pneumoniae. The histopathological analysis of lungs was per-
formed to validate the novel non-invasive intra-tracheal infection
method. Animals were infected and lungs were excised aseptically
at different times post infection. 5 mm cryo-sections of lungs tissue
of infected and control mice were fixed and stained for the
presence of C. pneumoniae antigen (red) and Mac-1+macrophag-
es (green). The lung epithelial cells were counter stained with
DAPI (blue). The sections were analyzed by epi-florescent
microscopy. Pictures shown here are typical examples of sections
analyzed from three independent repeats.
Found at: doi:10.1371/journal.pone.0006519.s002 (1.30 MB TIF)
Figure S2 Disruption of IAP levels in cIAP-1 KO macrophages.
(A) Mac-1+macrophage from both WT and cIAP-1 KO mice were
isolated. Total protein lysates were prepared from 1610E6
macrophages as described and 20 mg of protein from WT and
cIAP-1 KO macrophage were separated by SDS-PAGE and the
blotted onto PVDF membrane. Levels of IAPs and beta-actin
(loading control) in these macrophages were detected by
immunoblot analysis using cIAP-1 (BD transduction), rabbit
polyclonal antiserum cIAP-2 (H-85) (Santa Cruz) and mouse
monoclonal XIAP (BD Transduction). (B) PCR genotyping of lung
tissue from wildtype and cIAP-1 KO mice. DNA extracted from
lung tissue of wildtype (WT) or cIAP-1 KO mice (KO) was
amplified with primers that bind to a sequence within exon 1 of
the cIAP-1 gene (ex1) or to a sequence in the neomycin gene (neo)
that was inserted into exon 1 of the cIAP-1 gene to generate KO
mice (neo).
Found at: doi:10.1371/journal.pone.0006519.s003 (0.42 MB TIF)
Figure S3 No increased apoptosis of ciap-1 KO macrophages
upon treatment with stimuli. A and B. 16106 macrophages from
both wildtype and cIAP-1 KO mice were isolated and cultured as
described. Apoptosis was evaluated by determining caspases-3/7
activity by the Caspase-GloH luminescent Assay. Macrophages
were stimulated with various inflammatory mediators (TNF-
alpha: 50 ng/ml; IFN-gamma: 50 ng/ml; LPS: 5 mg/ml; Sodi-
um nitroprusside (SNP): 300 nM) and their response was
monitored after 24 h (A) and 48 h (B) post treatment. Neither
of the treatments elicited an apoptotic response in wildtype or
cIAP-1 KO macrophages. Data are represented as mean of
luminescence6SEM from two independent experiments with
similar results. (C) Determination of macrophages viability.
Macrophages treated with inflammatory cytokines and their
survival was measured by MTT dye reduction method. The
macrophages under above treatments were incubated with MTT
dye and The amount of purple formazon crystals formed as a
result of itsreduction was measured at 570 nm by a spectrometer,
Spectra max 250 (Molecular Devices, Munich, Germany). Data
are represented as mean OD6SEM from three independent
experiments.
Found at: doi:10.1371/journal.pone.0006519.s004 (0.25 MB TIF)
Figure S4 No effect of cIAP-1 in the control of Salmonella
infection and toxicity Intravenous infection of C57BL/6 and KO
cIAP-1 mice with Salmonella Typhimurium. C57BL/6 and KO
cIAP-1 mice were infected with 500 colony forming units (cfu)
Salmonella Typhimurium SL1344 via a tail vein. A. cfu per spleen
were determined 5 days post infection. Bacterial load is equivalent
in both C57BL/6 and KO cIAP mice. B. Survival was monitored
over one week after infection. All mice were dead 6 days post
infection without any significant difference in C57BL/6 or KO
cIAP-1 mice.
Found at: doi:10.1371/journal.pone.0006519.s005 (0.16 MB TIF)
Table S1
Found at: doi:10.1371/journal.pone.0006519.s006 (0.03 MB
DOC)
Table S2
Found at: doi:10.1371/journal.pone.0006519.s007 (0.03 MB
DOC)
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